| Property | Value | [@conti2005] |
|----------|-------| [@kortmann2015] |
| Gene Symbol | NLRC3 |
| Full Name | NLR Family CARD Domain Containing 3 |
| Chromosomal Location | 16p13.3 |
| NCBI Gene ID | 81128 |
| OMIM ID | 611362 |
| Ensembl ID | ENSG00000167900 |
| UniProt ID | Q7RTV0 |
| Encoded Protein | NLR family CARD domain-containing protein 3 |
| Associated Diseases | Cancer, Inflammatory Conditions, Alzheimer's Disease, Parkinson's Disease |
NLRC3 (NLR Family CARD Domain Containing 3), also known as NLR family CARD domain-containing protein 3 or NOD3, is a member of the NOD-like receptor (NLR) family of proteins. Located on chromosome 16p13.3, NLRC3 encodes a 755-amino acid protein that possesses unique structural features distinguishing it from other NLR family members. Unlike classical NLR proteins such as NLRP3 or NLRC4, NLRC3 contains a TIR (Toll/Interleukin-1 Receptor) domain, placing it at the intersection of NLR and TLR signaling pathways.
NLRC3 is expressed in various tissues, with highest expression in immune cells and epithelial tissues. It plays important roles in regulating innate immune responses, inflammatory signaling, cell cycle regulation, and DNA damage responses. Emerging research has revealed NLRC3 expression in microglia and neurons, where it may modulate neuroinflammatory responses relevant to Alzheimer's Disease and Parkinson's Disease pathogenesis.
The NLRC3 gene is located on chromosome 16p13.3 (positions 3,800,000-3,850,000, GRCh38) on the minus strand. The gene spans approximately 22 kb and comprises 14 exons that encode a 755-amino acid protein with a molecular weight of approximately 85 kDa.
NLRC3 contains several distinct functional domains:
The presence of the TIR domain is unique among NLR proteins and suggests distinct signaling mechanisms compared to other NLR family members.
NLRC3 shows conservation across vertebrates:
| Species | Gene Name | Amino Acids | Function |
|---|---|---|---|
| Human | NLRC3 | 755 | Reference |
| Mouse | Nlrc3 | 752 | 78% identity |
| Zebrafish | nlrc3 | 738 | 52% identity |
| Chicken | NLRC3 | 749 | 75% identity |
NLRC3 possesses several unique structural characteristics:
NLRC3 participates in multiple cellular processes [@kortmann2015]:
NLRC3 plays critical roles in immune cell function [@javierre2010]:
NLRC3 responds to various cellular stresses:
In non-immune tissues, NLRC3 maintains:
As characterized in [@zhang2021], NLRC3 shows tumor suppressor activity:
NLRC3 has emerging roles in neurodegeneration [@schneider2023]:
Microglial function [@kuang2020]:
Inflammatory regulation:
Pathology relationships:
Neuroinflammation:
Microglial activation:
NLRC3 shows broad but specific expression:
| Tissue | Expression Level | Notable Cell Types |
|---|---|---|
| Lung | High | Epithelial cells, alveolar macrophages |
| Spleen | High | T cells, B cells, macrophages |
| Brain | Moderate | Microglia, neurons |
| Intestine | Moderate | Intestinal epithelial cells |
| Heart | Low-moderate | Cardiomyocytes |
| Liver | Low | Hepatocytes |
Within the central nervous system, NLRC3 is expressed in:
NLRC3 modulates the NF-κB signaling pathway:
As a TIR domain-containing protein, NLRC3 interacts with:
Unlike NLRP3, NLRC3 generally inhibits inflammasome activation:
NLRC3 expression may serve as:
Current therapeutic strategies include:
Activation approaches (for neurodegeneration):
Inhibition strategies (for cancer):
Key questions remain:
| Interactor | Interaction Type | Function |
|---|---|---|
| MyD88 | TIR-TIR | TLR signaling adapter |
| NF-κB pathway | Modulation | Inhibits activation |
| p53 | Regulation | Cell cycle control |
| ATM/ATR | DNA damage | Genomic stability |